Prosonix Limited was established, following their acquisition of the C3 Technology business from Accentus plc on March 31, 2006. Based in Oxford UK and Experts in Sound ScienceTM, Prosonix are acknowledged leaders in the commercialization of proprietary ultrasonic particle engineering technologies and added value ultrasonic process chemistry solutions for the pharmaceutical and related industries.Prosonix’s core markets are in the Pharmaceutical and Chemical industries.